Global Oral Anti-allergic Drugs Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Oral Anti-allergic Drugs Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Antihistamine Drugs
- 1.3.3 Allergic Mediator Release Agent
- 1.3.4 Immunosuppressant Drugs
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Oral Anti-allergic Drugs Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Hospital Pharmacies
- 1.4.3 Retail Pharmacies
- 1.4.4 Online Pharmacies
- 1.5 Global Oral Anti-allergic Drugs Market Size & Forecast
- 1.5.1 Global Oral Anti-allergic Drugs Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global Oral Anti-allergic Drugs Sales Quantity (2021-2032)
- 1.5.3 Global Oral Anti-allergic Drugs Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Sanofi
- 2.1.1 Sanofi Details
- 2.1.2 Sanofi Major Business
- 2.1.3 Sanofi Oral Anti-allergic Drugs Product and Services
- 2.1.4 Sanofi Oral Anti-allergic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Sanofi Recent Developments/Updates
- 2.2 Johnson & Johnson
- 2.2.1 Johnson & Johnson Details
- 2.2.2 Johnson & Johnson Major Business
- 2.2.3 Johnson & Johnson Oral Anti-allergic Drugs Product and Services
- 2.2.4 Johnson & Johnson Oral Anti-allergic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Johnson & Johnson Recent Developments/Updates
- 2.3 Merck
- 2.3.1 Merck Details
- 2.3.2 Merck Major Business
- 2.3.3 Merck Oral Anti-allergic Drugs Product and Services
- 2.3.4 Merck Oral Anti-allergic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Merck Recent Developments/Updates
- 2.4 Teva
- 2.4.1 Teva Details
- 2.4.2 Teva Major Business
- 2.4.3 Teva Oral Anti-allergic Drugs Product and Services
- 2.4.4 Teva Oral Anti-allergic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Teva Recent Developments/Updates
- 2.5 GlaxoSmithKline
- 2.5.1 GlaxoSmithKline Details
- 2.5.2 GlaxoSmithKline Major Business
- 2.5.3 GlaxoSmithKline Oral Anti-allergic Drugs Product and Services
- 2.5.4 GlaxoSmithKline Oral Anti-allergic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 GlaxoSmithKline Recent Developments/Updates
- 2.6 Bayer
- 2.6.1 Bayer Details
- 2.6.2 Bayer Major Business
- 2.6.3 Bayer Oral Anti-allergic Drugs Product and Services
- 2.6.4 Bayer Oral Anti-allergic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Bayer Recent Developments/Updates
- 2.7 Almirall
- 2.7.1 Almirall Details
- 2.7.2 Almirall Major Business
- 2.7.3 Almirall Oral Anti-allergic Drugs Product and Services
- 2.7.4 Almirall Oral Anti-allergic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Almirall Recent Developments/Updates
- 2.8 Pfizer
- 2.8.1 Pfizer Details
- 2.8.2 Pfizer Major Business
- 2.8.3 Pfizer Oral Anti-allergic Drugs Product and Services
- 2.8.4 Pfizer Oral Anti-allergic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 Pfizer Recent Developments/Updates
- 2.9 AstraZeneca
- 2.9.1 AstraZeneca Details
- 2.9.2 AstraZeneca Major Business
- 2.9.3 AstraZeneca Oral Anti-allergic Drugs Product and Services
- 2.9.4 AstraZeneca Oral Anti-allergic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 AstraZeneca Recent Developments/Updates
- 2.10 Sun Pharma
- 2.10.1 Sun Pharma Details
- 2.10.2 Sun Pharma Major Business
- 2.10.3 Sun Pharma Oral Anti-allergic Drugs Product and Services
- 2.10.4 Sun Pharma Oral Anti-allergic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.10.5 Sun Pharma Recent Developments/Updates
- 2.11 Novartis
- 2.11.1 Novartis Details
- 2.11.2 Novartis Major Business
- 2.11.3 Novartis Oral Anti-allergic Drugs Product and Services
- 2.11.4 Novartis Oral Anti-allergic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.11.5 Novartis Recent Developments/Updates
- 2.12 Boehringer Ingelheim
- 2.12.1 Boehringer Ingelheim Details
- 2.12.2 Boehringer Ingelheim Major Business
- 2.12.3 Boehringer Ingelheim Oral Anti-allergic Drugs Product and Services
- 2.12.4 Boehringer Ingelheim Oral Anti-allergic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.12.5 Boehringer Ingelheim Recent Developments/Updates
- 2.13 UCB Pharma
- 2.13.1 UCB Pharma Details
- 2.13.2 UCB Pharma Major Business
- 2.13.3 UCB Pharma Oral Anti-allergic Drugs Product and Services
- 2.13.4 UCB Pharma Oral Anti-allergic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.13.5 UCB Pharma Recent Developments/Updates
- 2.14 Yangtze River Pharmaceutical Group
- 2.14.1 Yangtze River Pharmaceutical Group Details
- 2.14.2 Yangtze River Pharmaceutical Group Major Business
- 2.14.3 Yangtze River Pharmaceutical Group Oral Anti-allergic Drugs Product and Services
- 2.14.4 Yangtze River Pharmaceutical Group Oral Anti-allergic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.14.5 Yangtze River Pharmaceutical Group Recent Developments/Updates
- 2.15 Hainan Poly Pharm
- 2.15.1 Hainan Poly Pharm Details
- 2.15.2 Hainan Poly Pharm Major Business
- 2.15.3 Hainan Poly Pharm Oral Anti-allergic Drugs Product and Services
- 2.15.4 Hainan Poly Pharm Oral Anti-allergic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.15.5 Hainan Poly Pharm Recent Developments/Updates
- 2.16 Chongqing Huapont Pharmaceutical
- 2.16.1 Chongqing Huapont Pharmaceutical Details
- 2.16.2 Chongqing Huapont Pharmaceutical Major Business
- 2.16.3 Chongqing Huapont Pharmaceutical Oral Anti-allergic Drugs Product and Services
- 2.16.4 Chongqing Huapont Pharmaceutical Oral Anti-allergic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.16.5 Chongqing Huapont Pharmaceutical Recent Developments/Updates
- 2.17 Dawnrays Pharma
- 2.17.1 Dawnrays Pharma Details
- 2.17.2 Dawnrays Pharma Major Business
- 2.17.3 Dawnrays Pharma Oral Anti-allergic Drugs Product and Services
- 2.17.4 Dawnrays Pharma Oral Anti-allergic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.17.5 Dawnrays Pharma Recent Developments/Updates
3 Competitive Environment: Oral Anti-allergic Drugs by Manufacturer
- 3.1 Global Oral Anti-allergic Drugs Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Oral Anti-allergic Drugs Revenue by Manufacturer (2021-2026)
- 3.3 Global Oral Anti-allergic Drugs Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Oral Anti-allergic Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Oral Anti-allergic Drugs Manufacturer Market Share in 2025
- 3.4.3 Top 6 Oral Anti-allergic Drugs Manufacturer Market Share in 2025
- 3.5 Oral Anti-allergic Drugs Market: Overall Company Footprint Analysis
- 3.5.1 Oral Anti-allergic Drugs Market: Region Footprint
- 3.5.2 Oral Anti-allergic Drugs Market: Company Product Type Footprint
- 3.5.3 Oral Anti-allergic Drugs Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Oral Anti-allergic Drugs Market Size by Region
- 4.1.1 Global Oral Anti-allergic Drugs Sales Quantity by Region (2021-2032)
- 4.1.2 Global Oral Anti-allergic Drugs Consumption Value by Region (2021-2032)
- 4.1.3 Global Oral Anti-allergic Drugs Average Price by Region (2021-2032)
- 4.2 North America Oral Anti-allergic Drugs Consumption Value (2021-2032)
- 4.3 Europe Oral Anti-allergic Drugs Consumption Value (2021-2032)
- 4.4 Asia-Pacific Oral Anti-allergic Drugs Consumption Value (2021-2032)
- 4.5 South America Oral Anti-allergic Drugs Consumption Value (2021-2032)
- 4.6 Middle East & Africa Oral Anti-allergic Drugs Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Oral Anti-allergic Drugs Sales Quantity by Type (2021-2032)
- 5.2 Global Oral Anti-allergic Drugs Consumption Value by Type (2021-2032)
- 5.3 Global Oral Anti-allergic Drugs Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Oral Anti-allergic Drugs Sales Quantity by Application (2021-2032)
- 6.2 Global Oral Anti-allergic Drugs Consumption Value by Application (2021-2032)
- 6.3 Global Oral Anti-allergic Drugs Average Price by Application (2021-2032)
7 North America
- 7.1 North America Oral Anti-allergic Drugs Sales Quantity by Type (2021-2032)
- 7.2 North America Oral Anti-allergic Drugs Sales Quantity by Application (2021-2032)
- 7.3 North America Oral Anti-allergic Drugs Market Size by Country
- 7.3.1 North America Oral Anti-allergic Drugs Sales Quantity by Country (2021-2032)
- 7.3.2 North America Oral Anti-allergic Drugs Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Oral Anti-allergic Drugs Sales Quantity by Type (2021-2032)
- 8.2 Europe Oral Anti-allergic Drugs Sales Quantity by Application (2021-2032)
- 8.3 Europe Oral Anti-allergic Drugs Market Size by Country
- 8.3.1 Europe Oral Anti-allergic Drugs Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Oral Anti-allergic Drugs Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Oral Anti-allergic Drugs Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Oral Anti-allergic Drugs Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Oral Anti-allergic Drugs Market Size by Region
- 9.3.1 Asia-Pacific Oral Anti-allergic Drugs Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Oral Anti-allergic Drugs Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Oral Anti-allergic Drugs Sales Quantity by Type (2021-2032)
- 10.2 South America Oral Anti-allergic Drugs Sales Quantity by Application (2021-2032)
- 10.3 South America Oral Anti-allergic Drugs Market Size by Country
- 10.3.1 South America Oral Anti-allergic Drugs Sales Quantity by Country (2021-2032)
- 10.3.2 South America Oral Anti-allergic Drugs Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Oral Anti-allergic Drugs Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Oral Anti-allergic Drugs Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Oral Anti-allergic Drugs Market Size by Country
- 11.3.1 Middle East & Africa Oral Anti-allergic Drugs Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Oral Anti-allergic Drugs Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Oral Anti-allergic Drugs Market Drivers
- 12.2 Oral Anti-allergic Drugs Market Restraints
- 12.3 Oral Anti-allergic Drugs Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Oral Anti-allergic Drugs and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Oral Anti-allergic Drugs
- 13.3 Oral Anti-allergic Drugs Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Oral Anti-allergic Drugs Typical Distributors
- 14.3 Oral Anti-allergic Drugs Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
According to our (Global Info Research) latest study, the global Oral Anti-allergic Drugs market size was valued at US$ 31600 million in 2025 and is forecast to a readjusted size of US$ 40660 million by 2032 with a CAGR of 3.7% during review period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Oral Anti-allergic Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Oral Anti-allergic Drugs market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Oral Anti-allergic Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Oral Anti-allergic Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Oral Anti-allergic Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Oral Anti-allergic Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Oral Anti-allergic Drugs market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, Johnson & Johnson, Merck, Teva, GlaxoSmithKline, Bayer, Almirall, Pfizer, AstraZeneca, Sun Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Oral Anti-allergic Drugs market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Antihistamine Drugs
Allergic Mediator Release Agent
Immunosuppressant Drugs
Market segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Major players covered
Sanofi
Johnson & Johnson
Merck
Teva
GlaxoSmithKline
Bayer
Almirall
Pfizer
AstraZeneca
Sun Pharma
Novartis
Boehringer Ingelheim
UCB Pharma
Yangtze River Pharmaceutical Group
Hainan Poly Pharm
Chongqing Huapont Pharmaceutical
Dawnrays Pharma
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Oral Anti-allergic Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Oral Anti-allergic Drugs, with price, sales quantity, revenue, and global market share of Oral Anti-allergic Drugs from 2021 to 2026.
Chapter 3, the Oral Anti-allergic Drugs competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oral Anti-allergic Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Oral Anti-allergic Drugs market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Oral Anti-allergic Drugs.
Chapter 14 and 15, to describe Oral Anti-allergic Drugs sales channel, distributors, customers, research findings and conclusion.